These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 5983123
1. [On the comparative efficacy of desferrioxamine and DTPA as agents for the elimination of plutonium in poisoned rats]. Truhaut R, Boudène C, Lutz M, Métivier H. Arch Mal Prof; 1966 Sep; 27(9):669-76. PubMed ID: 5983123 [No Abstract] [Full Text] [Related]
2. [Research in the complexon series. I. Detoxicant capacity of Ca-DTPA in experimental chronic plutonium poisoning in rats. II. Influence of the repeated intravenous administration of Ca-DTPA on the elimination of trace elements in rats. 3. Preliminary results of the study, in rats, of the modalities of calcium elimination after Ca45-DTPA injection]. Truhaut R, Boudène C, Lutz M. Ann Biol Clin (Paris); 1966 Sep; 24(3):419-39. PubMed ID: 5932716 [No Abstract] [Full Text] [Related]
7. Metabolic and therapeutic studies of plutonium. IV. ANL-7535. Lindenbaum A, Rosenthal MW, Lund CJ, Russell JJ, Smoler MH, Moretti ES, Brown H. ANL Rep; 1968 Dec; ():60-5. PubMed ID: 5306872 [No Abstract] [Full Text] [Related]
8. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms. Sérandour AL, Tsapis N, Gervelas C, Grillon G, Fréchou M, Deverre JR, Bénech H, Fattal E, Fritsch P, Poncy JL. Radiat Prot Dosimetry; 2007 Dec; 127(1-4):472-6. PubMed ID: 17562654 [Abstract] [Full Text] [Related]
10. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments. Fritsch P, Sérandour AL, Grémy O, Phan G, Tsapis N, Abram MC, Renault D, Fattal E, Benech H, Deverre JR, Poncy JL. Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474 [Abstract] [Full Text] [Related]
11. Effectiveness of early DTPA treatments in two types of plutonium exposures in humans. Lagerquist CR, Hammond SE, Putzier EA, Piltingsrud CW. Health Phys; 1965 Nov; 11(11):1177-80. PubMed ID: 5867870 [No Abstract] [Full Text] [Related]
13. In vivo and in vitro chelation of plutonium by alpha-lipoic acid and DTPA. BNWL-714. Dilley JV. BNWL Rep; 1968 May; ():6.12-6+. PubMed ID: 4898101 [No Abstract] [Full Text] [Related]
14. Effect of ascorbate ions in DTPA treatment after contamination by mixed plutonium dioxide-sodium burning products. Métvier H, Masse R, Nolibé D, Nénot JC, Lafuma J. Health Phys; 1977 May; 32(5):450-2. PubMed ID: 881345 [No Abstract] [Full Text] [Related]
15. Efficacy of Zn-DTPA and Ca-DTPA in removing plutonium from the human body. Ohlenschläger L, Schieferdecker H, Schmidt-Martin W. Health Phys; 1978 Nov; 35(5):694-9. PubMed ID: 744734 [No Abstract] [Full Text] [Related]
17. Efficacy of Zn-DTPA in removing plutonium from the human body. Ohlenschläger L. Health Phys; 1976 Feb; 30(2):249-50. PubMed ID: 1245431 [No Abstract] [Full Text] [Related]